PT80079B - Processo para a preparacao de composicoes farmaceuticas anti-virus contendo 2-dietilamino-2',6'-acetoxilida (lidocaina) - Google Patents

Processo para a preparacao de composicoes farmaceuticas anti-virus contendo 2-dietilamino-2',6'-acetoxilida (lidocaina)

Info

Publication number
PT80079B
PT80079B PT80079A PT8007985A PT80079B PT 80079 B PT80079 B PT 80079B PT 80079 A PT80079 A PT 80079A PT 8007985 A PT8007985 A PT 8007985A PT 80079 B PT80079 B PT 80079B
Authority
PT
Portugal
Prior art keywords
lidocaine
dietilamino
acetoxylid
preparation
pharmaceutical compositions
Prior art date
Application number
PT80079A
Other languages
English (en)
Other versions
PT80079A (en
Inventor
Harold Gray Haines
Caroline Burgess Dickens
Original Assignee
Brigham Dana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham Dana filed Critical Brigham Dana
Publication of PT80079A publication Critical patent/PT80079A/pt
Publication of PT80079B publication Critical patent/PT80079B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT80079A 1984-03-08 1985-03-08 Processo para a preparacao de composicoes farmaceuticas anti-virus contendo 2-dietilamino-2',6'-acetoxilida (lidocaina) PT80079B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/587,398 US4628063A (en) 1984-03-08 1984-03-08 Antiviral pharmaceutical preparations and methods for their use

Publications (2)

Publication Number Publication Date
PT80079A PT80079A (en) 1985-04-01
PT80079B true PT80079B (pt) 1987-09-18

Family

ID=24349633

Family Applications (1)

Application Number Title Priority Date Filing Date
PT80079A PT80079B (pt) 1984-03-08 1985-03-08 Processo para a preparacao de composicoes farmaceuticas anti-virus contendo 2-dietilamino-2',6'-acetoxilida (lidocaina)

Country Status (13)

Country Link
US (2) US4628063A (pt)
EP (1) EP0154344B1 (pt)
JP (1) JPH0676317B2 (pt)
AT (1) ATE91233T1 (pt)
AU (1) AU571072B2 (pt)
DE (1) DE3587434T2 (pt)
ES (1) ES8700053A1 (pt)
IE (1) IE61525B1 (pt)
IL (1) IL74535A (pt)
NZ (1) NZ211361A (pt)
PT (1) PT80079B (pt)
WO (1) WO1985003862A1 (pt)
ZA (1) ZA851765B (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5316775A (en) * 1988-08-04 1994-05-31 Kremers-Urban Company Method of treating hepatitis B infection
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
SE8804214L (sv) * 1988-11-22 1990-05-23 Jean Cassuto Antiinflammatoriskt och antiinfektioest medikament
US4997853A (en) * 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US5331012A (en) * 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
GB9027433D0 (en) * 1990-12-18 1991-02-06 Merrell Dow Pharma Anti-herpes castanospermine esters
JP3115625B2 (ja) * 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
CA2130291A1 (en) * 1993-08-18 1995-02-19 Juan Carlos Mahiques Therapeutic uses of known ester and amide compounds
EP0643964A3 (en) * 1993-08-18 1995-08-09 Medipharma Sa Use of local anesthetics for the manufacture of a medicament for protecting the membranes of plasma cells.
US5506236A (en) * 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5776859A (en) * 1995-11-15 1998-07-07 Nickel; Alfred A. Sodium channel active novel compounds and related processes and bioassay techniques
US5869446A (en) * 1996-07-09 1999-02-09 Gambit International Limited Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections
DE19823319A1 (de) * 1998-05-26 1999-12-02 Karl Engelhard, Fabrik Pharm.- Praeparate Gmbh & Co. Kg Topisch anwendbares Arzneimittel zur Behandlung von Virusinfektionen
US6093417A (en) * 1999-01-11 2000-07-25 Advanced Medical Instruments Composition to treat ear disorders
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
NZ540166A (en) 2002-10-25 2007-06-29 Foamix Ltd Cosmetic and pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
AU2006298442A1 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
ITRM20060163A1 (it) * 2006-03-24 2007-09-25 Ist Farmacoterapico It Spa Composizione spray ad uso topico per il tratamento e la prevenzione delle infezioni labiali da herpes simplex
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
IT201800007009A1 (it) * 2018-07-06 2020-01-06 Nuovo uso medico di anestetici locali

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1315727A (fr) * 1961-06-13 1963-01-25 Perfectionnement aux véhicules-jouets
RO75309A2 (ro) * 1978-10-24 1981-12-25 Intreprinderea De Antibiotice,Ro Unguent medicamentos pentru tratamentul zonei zoster
FR2484257A1 (fr) * 1980-06-16 1981-12-18 Girard Michele Composition polyvitaminee pour le traitement de l'herpes

Also Published As

Publication number Publication date
WO1985003862A1 (en) 1985-09-12
EP0154344A2 (en) 1985-09-11
PT80079A (en) 1985-04-01
AU571072B2 (en) 1988-03-31
IE850581L (en) 1985-09-08
JPH0676317B2 (ja) 1994-09-28
ZA851765B (en) 1985-11-27
US4757088A (en) 1988-07-12
DE3587434D1 (de) 1993-08-12
JPS61501325A (ja) 1986-07-03
EP0154344A3 (en) 1990-06-13
IL74535A0 (en) 1985-06-30
IL74535A (en) 1988-12-30
DE3587434T2 (de) 1994-02-17
ES8700053A1 (es) 1986-10-16
ATE91233T1 (de) 1993-07-15
AU4067385A (en) 1985-09-24
IE61525B1 (en) 1994-11-16
EP0154344B1 (en) 1993-07-07
NZ211361A (en) 1988-07-28
ES541103A0 (es) 1986-10-16
US4628063A (en) 1986-12-09

Similar Documents

Publication Publication Date Title
PT80079B (pt) Processo para a preparacao de composicoes farmaceuticas anti-virus contendo 2-dietilamino-2',6'-acetoxilida (lidocaina)
PT82580B (pt) Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
ATE231839T1 (de) Polyaromatische antivirale zusammensetzungen
DE3581819D1 (de) Pyridazinamine wirksam gegen viren.
EA199901031A1 (ru) Производные бензимидазола
BRPI9913945B8 (pt) Composição farmacêutica rapidamente atuante para a administração sublingual de um agente farmacêutico para o tratamento de distúrbios agudos
PT88930A (pt) Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem
EP0270317A3 (en) Pharmaceutical compositions for the treatment of diseases caused by viruses
BR9007758A (pt) Processo para inibir o crescimento ou replicacao dos virus da imuno deficiencia humana,compostos,composto intermediario e formulacao farmaceutica para inibir o crescimento ou replicacao do hiv
EP0173092A3 (en) Anti viral composition
BR9813319A (pt) Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto
IT8123940A0 (it) Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo.
BR8702808A (pt) Processo para preparar 1,3,5-triazin-2,4,6-trionas trissubstituidas,composicoes para combate de pragas,aplicacao dos compostos mencionados,bem como processos para combate de pragas e para preparar tais composicoes
CA2029863A1 (en) Compositions and methods for treating viral infections
PT81345B (pt) Processo para a preparacao de novos peptideos activos sobre o sistema nervoso central com accao sobre o sistema colinergico, e de composicoes farmaceuticas contendo estes compostos
BR8203473A (pt) Processo para a preparacao de um 2,3-di-hidrobenzofurano 7-substituido composicao presticida e processo para combater pestes
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
BR8504044A (pt) Processo para a preparacao de fenilureias substituidas,composicoes herbicidas,processos para combater ervas daninhas e para a preparacao de composicoes
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
PT90816A (pt) Processo para a preparacao de composicoes farmaceuticas contendo analogos de 2',5'-oligoadenilato
BR8800530A (pt) Aminometiltetrahidrofuranos processo para sua preparacao,composicoes praguicidas,processos para combater pragas e para preparacao de composicoes tetrahidrofuranos e processo para sua preparacao
SE8802193D0 (sv) Externally applicable, antiviral pharmaceutical composition accumulating in the skin and process for the preparation of the same
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
IT1157268B (it) Derivati dagli acidi alfa o beta mercaptopropionilammidoacetici, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960731